OBJECTIVES: To establish the degree of erythrocyte membrane protein carbamylation in uremic and nonuremic patients, and to characterize the in vitro binding of cyanate to the individual proteins of the cytoskeletal matrix. DESIGN AND METHODS: For in vivo studies, erythrocyte ghosts were digested with proteinase K and the released peptides colorimetrically assayed for carbamylation, using the diacetyl monoxime reagent, and quantitated using homocitrulline. For in vitro studies, erythrocyte ghosts were incubated with [14C] cyanate, and the membrane proteins separated by SDS-PAGE. Cyanate incorporation was quantitated by liquid scintillation counting and imaging densitometry of the excised bands. RESULTS: Erythrocytes from uremic patients were found to have a greater level of carbamylation than those from nonuremic patients (47.09 +/- 7.80 and 25.89 +/- 6.92 nmol homocitrulline/mg proteolyzed protein released, respectively). In vitro incorporation of [14C] cyanate into membrane protein followed the sequence: spectrin > ankyrin > Band 4.1 > Band 3 > actin > Band 7. CONCLUSIONS: The increased level of erythrocyte membrane protein carbamylation in uremic compared to nonuremic patients may lead to membrane destabilization and contribute to the decreased erythrocyte survival time observed in uremia.
OBJECTIVES: To establish the degree of erythrocyte membrane protein carbamylation in uremic and nonuremic patients, and to characterize the in vitro binding of cyanate to the individual proteins of the cytoskeletal matrix. DESIGN AND METHODS: For in vivo studies, erythrocyte ghosts were digested with proteinase K and the released peptides colorimetrically assayed for carbamylation, using the diacetyl monoxime reagent, and quantitated using homocitrulline. For in vitro studies, erythrocyte ghosts were incubated with [14C] cyanate, and the membrane proteins separated by SDS-PAGE. Cyanate incorporation was quantitated by liquid scintillation counting and imaging densitometry of the excised bands. RESULTS: Erythrocytes from uremic patients were found to have a greater level of carbamylation than those from nonuremic patients (47.09 +/- 7.80 and 25.89 +/- 6.92 nmol homocitrulline/mg proteolyzed protein released, respectively). In vitro incorporation of [14C] cyanate into membrane protein followed the sequence: spectrin > ankyrin > Band 4.1 > Band 3 > actin > Band 7. CONCLUSIONS: The increased level of erythrocyte membrane protein carbamylation in uremic compared to nonuremic patients may lead to membrane destabilization and contribute to the decreased erythrocyte survival time observed in uremia.
Authors: Eugene O Apostolov; Debarti Ray; Wilson M Alobuia; Marina V Mikhailova; Xiaoying Wang; Alexei G Basnakian; Sudhir V Shah Journal: Am J Physiol Heart Circ Physiol Date: 2011-04-01 Impact factor: 4.733
Authors: Eugene O Apostolov; Debarti Ray; Alena V Savenka; Sudhir V Shah; Alexei G Basnakian Journal: J Am Soc Nephrol Date: 2010-10-14 Impact factor: 10.121
Authors: Veronika Binder; Barbara Chruścicka-Smaga; Brith Bergum; Stéphane Jaisson; Philippe Gillery; Joar Sivertsen; Tor Hervig; Marta Kaminska; Ronak Tilvawala; Venkatesh V Nemmara; Paul R Thompson; Jan Potempa; Hans-Peter Marti; Piotr Mydel Journal: J Am Soc Nephrol Date: 2022-08-29 Impact factor: 14.978
Authors: J'Neka S Claxton; Pablo C Sandoval; Gary Liu; Chung-Lin Chou; Jason D Hoffert; Mark A Knepper Journal: PLoS One Date: 2013-12-26 Impact factor: 3.240
Authors: Veronika Binder; Brith Bergum; Stéphane Jaisson; Philippe Gillery; Carsten Scavenius; Endy Spriet; Anne Karin Nyhaug; Helen M Roberts; Iain L C Chapple; Annelie Hellvard; Nicolas Delaleu; Piotr Mydel Journal: Thromb Haemost Date: 2017-04-06 Impact factor: 5.249